Detalles de la búsqueda
1.
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis.
PLoS Med
; 14(5): e1002309, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28552987
2.
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.
J Clin Oncol
; 36(17): 1685-1694, 2018 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29489427
Resultados
1 -
2
de 2
1
Próxima >
>>